This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Scopa, C. D. Articles by Chrousos, G. P. Search for Related Content PubMed PubMed Citation Articles by Scopa, C. D. Articles by Chrousos, G. P.

American Journal of Pathology, Vol 145, 1159-1167, Copyright © 1994 by American Society for Investigative Pathology

REGULAR ARTICLES

Presence of immunoreactive corticotropin releasing hormone in thyroid lesions

CD Scopa, G Mastorakos, TC Friedman, M Melachrinou, MJ Merino and GP Chrousos
Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892.

Corticotropin-releasing hormone (CRH) functions as a regulator of the hypothalamic-pituitary-adrenal axis and coordinator of the stress response. Immunoreactive CRH (IrCRH) is also produced in a variety of inflammatory sites, where this peptide acts as a proinflammatory cytokine. To detect CRH in autoimmune thyroid disease as well as in disorders that may be associated with an inflammatory reaction within this gland, we examined immunohistochemically 45 thyroid lesions, including 12 nodular goiters, 9 cases of Hashimoto thyroiditis, 6 follicular adenomas, 4 follicular and 8 papillary carcinomas, 4 Hurthle cell tumors, 1 medullary cancer, and 1 insular thyroid carcinoma. We also examined the presence of IrCRH in the adjacent normal thyroid parenchyma. The avidin-biotin complex method was employed on formalin- fixed, paraffin-embedded tissue, using a highly specific, affinity- purified polyclonal rabbit anti-CRH antibody. Granular cytoplasmic immunostaining of follicular cells was observed in 100% of the cases of Hashimoto thyroiditis, 77% of the neoplasms and 42% of goiters. The intensity of the staining was more pronounced in Hashimoto thyroiditis and Hurthle cell tumors, whereas the remaining lesions exhibited a heterogeneous staining pattern. No IrCRH was observed in the normal thyroid parenchyma. Using a specific radioimmunoassay, the IrCRH in extracts of simple thyroid goiters, papillary carcinomas, and Hurthle cell tumors ranged between 0.031 and 0.224 pmol/g of wet tissue but was undetectable in normal thyroid parenchyma. The IrCRH molecule in the thyroid gland eluted at the same fraction as synthetic rat/human CRH 1- 41 in reverse phase high pressure liquid chromatography. We conclude that IrCRH is present in thyroid lesions, predominantly in those related to autoimmune phenomena, suggesting that this neuropeptide may be directly and/or indirectly involved with inflammatory processes taking place in this gland.

This article has been cited by other articles:

				J. Gay, E. Kokkotou, M. O'Brien, C. Pothoulakis, and K. P. Karalis Corticotropin-Releasing Hormone Deficiency Is Associated with Reduced Local Inflammation in a Mouse Model of Experimental Colitis Endocrinology, July 1, 2008; 149(7): 3403 - 3409. [Abstract] [Full Text] [PDF]

				E ZOUMAKIS, K. C RICE, P.W GOLD, and G. P CHROUSOS Potential Uses of Corticotropin-Releasing Hormone Antagonists Ann. N.Y. Acad. Sci., November 1, 2006; 1083(1): 239 - 251. [Abstract] [Full Text] [PDF]

				G. Mastorakos, E. I Karoutsou, and M. Mizamtsidi Corticotropin releasing hormone and the immune/inflammatory response Eur. J. Endocrinol., November 1, 2006; 155(suppl_1): S77 - S84. [Abstract] [Full Text] [PDF]

				E Zoumakis, D K Grammatopoulos, and G P Chrousos Corticotropin-releasing hormone receptor antagonists Eur. J. Endocrinol., November 1, 2006; 155(suppl_1): S85 - S91. [Abstract] [Full Text] [PDF]

				H. Sashinami, K. Kageyama, T. Suda, and A. Nakane Urocortin 2 Suppresses Host Resistance to Listeria monocytogenes Infection via Up-Regulation of Interleukin-10 Endocrinology, November 1, 2005; 146(11): 5003 - 5011. [Abstract] [Full Text] [PDF]

				P. M. Anton, J. Gay, A. Mykoniatis, A. Pan, M. O'Brien, D. Brown, K. Karalis, and C. Pothoulakis Corticotropin-releasing hormone (CRH) requirement in Clostridium difficile toxin A-mediated intestinal inflammation PNAS, June 1, 2004; 101(22): 8503 - 8508. [Abstract] [Full Text] [PDF]

				G. MASTORAKOS and I. ILIAS Maternal and Fetal Hypothalamic-Pituitary-Adrenal Axes During Pregnancy and Postpartum Ann. N.Y. Acad. Sci., November 1, 2003; 997(1): 136 - 149. [Abstract] [Full Text] [PDF]

				D. M. Tamimi The Association Between Chronic Lymphocytic Thyroiditis and Thyroid Tumors International Journal of Surgical Pathology, April 1, 2002; 10(2): 141 - 146. [Abstract] [PDF]

				T.M. O'CONNOR, D.J. O'HALLORAN, and F. SHANAHAN The stress response and the hypothalamic-pituitary-adrenal axis: from molecule to melancholia QJM, June 1, 2000; 93(6): 323 - 333. [Abstract] [Full Text] [PDF]

				C. M. BAMBERGER and A.-M. BAMBERGER The Peripheral CRH/Urocortin System Ann. N.Y. Acad. Sci., January 1, 2000; 917(1): 290 - 296. [Abstract] [Full Text] [PDF]

				Y. FUNASAKA, H. SATO, and M. ICHIHASHI Expression of Corticotropin Releasing Hormone in Malignant Melanoma Ann. N.Y. Acad. Sci., October 20, 1999; 885(1): 391 - 393. [Full Text] [PDF]

				K. P. Karalis, E. Kontopoulos, L. J. Muglia, and J. A. Majzoub Corticotropin-releasing hormone deficiency unmasks the proinflammatory effect of epinephrine PNAS, June 8, 1999; 96(12): 7093 - 7097. [Abstract] [Full Text] [PDF]

				T. C. Theoharides, L. K. Singh, W. Boucher, X. Pang, R. Letourneau, E. Webster, and G. Chrousos Corticotropin-Releasing Hormone Induces Skin Mast Cell Degranulation and Increased Vascular Permeability, A Possible Explanation for Its Proinflammatory Effects Endocrinology, January 1, 1998; 139(1): 403 - 413. [Abstract] [Full Text] [PDF]

				G. P. Chrousos The Hypothalamic-Pituitary-Adrenal Axis and Immune-Mediated Inflammation N. Engl. J. Med., May 18, 1995; 332(20): 1351 - 1363. [Full Text] [PDF]